Insights, analysis, and strategies focused on Competitive Intelligence.
Know more about our Pharmaceutical Competitive Intelligence ServicesAlso checkout our Pharmaceutical Strategic Insights
The radioligand therapy market is growing rapidly, driven by rising cancer cases, advances in nuclear medicine, and targeted therapies using radioisotopes like Lutetium-177 and Actinium-225.
January 29, 2026
September 15, 2025
May 7, 2025
May 5, 2025
April 30, 2025